A new way to evaluate real-world biomarker data is coming
Get early access to explore biomarker prevalence across external datasets- no contracts, integrations, or procurement required.
Soon, you'll be able to validate real-world biomarker coverage across datma's federated network of participating institutions- all before committing time or budget.
The Federated Biomarker Explorer gives you aggregate, cohort-level visibility into biomarker presence to help you assess feasibility upfront.